1. Curcumin sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis through reactive oxygen species-mediated upregulation of death receptor 5 (DR5)
   Eun Mi Jung et al, 2005, Carcinogenesis CrossRef
2. Multiple mechanisms underlie resistance of leukemia cells to Apo2 Ligand/TRAIL
   Jinrong Cheng et al, 2006, Molecular Cancer Therapeutics CrossRef
3. Potential use of alexidine dihydrochloride as an apoptosis-promoting anticancer agent
   Kenneth W. Yip et al, 2006, Molecular Cancer Therapeutics CrossRef
4. p53 Upregulates Death Receptor 4 Expression through an Intronic p53 Binding Site
   Xiangguo Liu et al, 2004, Cancer Research CrossRef
5. Enhancing the Effect of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Signaling and Arginine Deprivation in Melanoma
   Chunjing Wu et al, 2021, International Journal of Molecular Sciences CrossRef
6. Mithramycin A sensitizes cancer cells to TRAIL-mediated apoptosis by down-regulation of XIAP gene promoter through Sp1 sites
   Tae-Jin Lee et al, 2006, Molecular Cancer Therapeutics CrossRef
7. Benzethonium Chloride: A Novel Anticancer Agent Identified by Using a Cell-Based Small-Molecule Screen
   Kenneth W. Yip et al, 2006, Clinical Cancer Research CrossRef
8. Contribution of Epigenetic Silencing of Tumor Necrosis Factor–Related Apoptosis Inducing Ligand Receptor 1 (DR4) to TRAIL Resistance and Ovarian Cancer
   Peter Horak et al, 2005, Molecular Cancer Research CrossRef
9. Andrographolide sensitizes cancer cells to TRAIL-induced apoptosis via p53-mediated death receptor 4 up-regulation
   Jing Zhou et al, 2008, Molecular Cancer Therapeutics CrossRef